Where are we with postmenopausal hormone therapy in 2005?
Explore this paper's citation graph
Summary
What the authors know and do not know about postmenopausal hormone therapy, including the evidence on novel choices such as raloxifene and tibolone are discussed, are discussed.
- Type
- article
- Published
- 2005-01-01
- Cited by
- 5
- References
- 55
- OpenAlex
- https://openalex.org/W16373243
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:43283776
Keywords
Political science, Humanities, Philosophy
References
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
- Tibolone and its effects on bone: a review
- Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus® study
- Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
- Estrogen replacement therapy and the risk of venous thrombosis.
- Safety and Adverse Effects Associated With Raloxifene: Multiple Outcomes of Raloxifene Evaluation
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
- Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials.
- Risk‐Benefit Profile for Raloxifene: 4‐Year Data From the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial
- Hormone replacement therapy and stroke: risk, protection or no effect?
- Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
- The effects of tibolone on mood and libido
- Prospective study of exogenous hormones and risk of pulmonary embolism in women.
- Hormone replacement therapy and cognition: systematic review and meta-analysis.
- Adverse events reported by postmenopausal women in controlled trials with raloxifene.
- Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
- The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
- Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study
- Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis.
Cited by
- Relationship between expression of gastrin, somatostatin, Fas/FasL and caspases in large intestinal carcinoma.
- Women's Hearts - Ischaemic Heart Disease and Stress Management in Women
- Hormone Therapy for the Management of Menopausal Symptoms
- Estrogen Receptors: Their Actions and Functional Roles in Health and Disease
Related papers
No related papers recorded.